Discontinuation report AMERGE
Report ID | 148427 |
Drug Identification Number | 02237820 |
Brand name | AMERGE |
Common or Proper name | Naratriptan Tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NARATRIPTAN |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | All pack sizes/ Tous les formats |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-08-05 |
Remaining supply date | 2024-02-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-08-09 | French | Compare |
v9 | 2022-08-09 | English | Compare |
v8 | 2022-08-05 | French | Compare |
v7 | 2022-08-05 | English | Compare |
v6 | 2022-07-29 | French | Compare |
v5 | 2022-07-29 | English | Compare |
v4 | 2022-04-06 | French | Compare |
v3 | 2022-04-06 | English | Compare |
v2 | 2021-10-28 | French | Compare |
v1 | 2021-10-28 | English | Compare |
Showing 1 to 10 of 10